Crime Against Humanity SSRIs/SNRIS/Antidepressants 2010-02-01 Global ++New Book by Lilly Executive Claims Drugmakers Knew of Potential for Homicides, Mass Shootings, etc
Summary:

Paragraphs two & three read:  "Many of the horrific school, workplace and mass shootings that have plagued parts of the world over the years may not have occurred if the pharmaceutical industry had been completely honest about the side effects of psychotropic medication, according to the new book Side Effects: Death – Confessions of a Pharma Insider by former executive director of the Swedish Branch of Eli Lilly & Company John Virapen."

"Virapen claims that anti-depressants and selective serotonin reuptake inhibitors (SSRIs) were known to have suicidal and homicidal side effects, even during clinical trials. Thanks to spin marketing and paid, positive articles in scientific journals, he points out, the adverse reactions were often ignored or given little thought by prescribing physicians and patients."


http://www.prlog.org/10514103-what-big-pharma-knows-side-effects-death.html



What Big Pharma Knows – “Side Effects: Death”

Former pharmaceutical executive director reveals industry secrets
 

FOR IMMEDIATE RELEASE
PR Log (Press Release)
Feb 01, 2010 – P.O. Box 9949, College Station, TX. 77842 • Phone/Fax: 877-376-4955
http://www.virtualbookworm.com • info@virtualbookworm.com

FOR IMMEDIATE RELEASE
Contact: Virtualbookworm.com Publishing Inc.
877-376-4955
reviews@virtualbookworm.com


What Big Pharma Knows – “Side Effects: Death”

Many of the horrific school, workplace and mass shootings that have plagued parts of the world over the years may not have occurred if the pharmaceutical industry had been completely honest about the side effects of psychotropic medication, according to the new book Side Effects: Death – Confessions of a Pharma Insider by former executive director of the Swedish Branch of Eli Lilly & Company John Virapen.

Virapen claims that anti-depressants and selective serotonin reuptake inhibitors (SSRIs) were known to have suicidal and homicidal side effects, even during clinical trials. Thanks to spin marketing and paid, positive articles in scientific journals, he points out, the adverse reactions were often ignored or given little thought by prescribing physicians and patients.

Virapen also asserts the pharmaceutical industry has engaged in bribery and other major forms of corruption to gain approval for and in the marketing of many drugs used to treat such conditions as Attention Deficit Hyperactivity Disorder (ADHD), schizophrenia, arthritis, pain, diabetes and many others. The industry also “makes up” illnesses to enhance sales and market shares, he says.

To boost sales, Virapen writes, large pharmaceutical corporations spend about $35,000–$40,000 per year and per practicing doctor to persuade them to prescribe their products. In addition to covering or “massaging” the negative effects of drugs, many of the companies engage in “off-label marketing,” which encourages physicians to prescribe the medicines for conditions for which they haven’t been approved, Virapen reveals.

Born in British Guyana, John Virapen went from a door-to-door conman to a pop star, to a pharmaceutical representative to executive director of one of the largest drug companies in the world. He admits to participating in bribery, false information and deception to help launch and market some of the most popularly prescribed (and most dangerous) drugs. In an effort to exorcise his demons and expose the tactics and dangers of the pharmaceutical industry, he wrote this expose.

The book has been published in four languages around the world and is a best-seller in Europe.

Side Effects: Death – Confessions of a Pharma Insider is available in softcover (ISBN 978-1-60264-516-5) and e-book (ISBN 978-1-60264-517-2) hardcover from Virtualbookworm.com, Amazon.com, and Barnesandnoble.com. This book can also be ordered from most bookstores around the United States and United Kingdom. More information can be found at the book’s official website, www.sideeffectsdeath.com.